Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AZ’s Forxiga gains EC, MHRA approvals for chronic kidney disease

pharmatimesAugust 09, 2021

Tag: MHRA , Forxiga , AstraZeneca , CKD

PharmaSources Customer Service